"To find answers, Mrs. Addario and her husband, along with David M. Jablons, her surgeon from the University of California, San Francisco, put together a two-day conference last fall of lung cancer researchers from major institutions around the world. She says the group identified a number of problems that hinder progress toward a cure. Among them: Researchers didn't know what others were doing, tissue and blood specimens needed for experiments weren't centrally located or shared, and the findings of experiments weren't integrated to help assess what the key priorities should be. Mrs. Addario [...]
SFGate (San Francisco Chronicle Online) reports on lung cancer survivor Bonnie J. Addario and her inspiration to start an organization, The Bonnie J. Addario Lung Cancer Foundation, to make strides in the fight against lung cancer. Addario received the Jefferson Award for her work.
Bonnie J. Addario broke barriers by becoming one of the country's top female oil company executives. Now, she is parlaying her professional prowess into running one of the country's largest lung-cancer foundations
Twenty-two years ago, with just a high school education, Addario started out as a secretary and [...]
Dr. Jasleen Kukreja "is not the first surgeon to perform a minimally invasive lobectomy at UCSF, but she may be a pioneer in the two-finger clamp technique, because her predecessors are men who have a tougher time squeezing in both fingers. Last summer, she became the first doctor to be hired by UCSF to focus primarily on this discipline."
Before an overflow crowd at the UCSF Comprehensive Cancer Center, members of the Thoracic Oncology Program speak about the challenges of lung cancer and the progress that has been made in finding effective treatments and one day a cure.
Adding their own contributions to a rapidly advancing
field, UCSF researchers - along with colleagues from
Incyte Corporation and the University of Texas Southwestern Medical
Center - have described new targets in lung cancer and evaluated a
promising new drug candidate that halts growth signals in tumor
cells grown in the lab. Their report is featured in the July issue of the
scientific journal Cancer Cell.
SFGate.com reports on the collaboration of David M. Jablons, M.D. and Jeff Peterson whose wife Karen and died from mesothelioma, a devastating disease.
Dr. David Jablons couldn't save Karen Peterson's life or even extend it. But he could give quality to whatever life she had left. That turned out to be about nine months, long enough for her twin boys to see her waterskiing on Lake Tahoe and boogie-boarding in Oceanside and laughing more than coughing.
Jablons, chief cardiothoracic surgeon at UCSF, was the last in a line of specialists Peterson had sought out coast to coast in a 22-month [...]
SFGate.com reports on the the journey of Mike Wooldridge after getting a devastating diagnosis and being turned away for surgery by M.D. Anderson, and being told it was incurable, only to get treatment at UCSF that enabled him to run in a marathon not long after that.
Running a marathon without a third of your right lung might seem impossible, but for Mike Wooldridge it's just another day on the road.
Diagnosed with a fist-sized tumor in his right lung a year ago, the Pleasant Hill Web site designer was initially given a 10 to 15 percent chance of surviving. Today he's running 30 miles a [...]
"We will discuss the most sophisticated approaches to lung cancer in the world," said David Jablons, MD, UCSF associate professor of surgery and program leader of the UCSF Thoracic Oncology Program. "Both the scope of the problem and the barriers to care in China are dramatic, but we hope this conference can help rally the international scientific community to address the crisis." Jablons, who conducts translational research into targeted cancer therapies, is director of the UCSF Thoracic Oncology Laboratory."